Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orison O Woolcott

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|April 30, 2021
Correction: Paszkiewicz et al. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting That Central Effects Can Be Avoided. <i>Int. J. Mol. Sci.</i> 2020, <i>21</i>, 6639Rebecca L Paszkiewicz, Richard N Bergman, Roberta S Santos, et al.
Obesity (Silver Spring, Md.)|May 24, 2023
Dapagliflozin prevents abdominal visceral and subcutaneous adipose tissue dysfunction in the insulin-resistant canine modelMorvarid Kabir, Richard N Bergman, Jay Porter, et al.
Endocrinology|January 17, 2014
Essentiality of portal vein receptors in hypoglycemic counterregulation: direct proof via denervation in male caninesViorica Ionut, Ana Valeria B Castro, Orison O Woolcott, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 9, 2006
Improvement of myocardial perfusion in coronary patients after intermittent hypobaric hypoxiaMaria del Pilar Valle, Félix García-Godos, Orison O Woolcott, et al.
Cell Calcium|April 20, 2006
Arachidonic acid is a physiological activator of the ryanodine receptor in pancreatic beta-cellsOrison O Woolcott, Amanda J Gustafsson, Mensur Dzabic, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 26, 2019
Activation of NPRs and UCP1-independent pathway following CB1R antagonist treatment is associated with adipose tissue beiging in fat-fed male dogsMalini S Iyer, Rebecca L Paszkiewicz, Richard N Bergman, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2014
Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemiaViorica Ionut, Ana Valeria B Castro, Orison O Woolcott, et al.
Plos One|July 12, 2016
Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-DiabetesViorica Ionut, Orison O Woolcott, Hasmik J Mkrtchyan, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 1, 2012
CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogsStella P Kim, Orison O Woolcott, Isabel R Hsu, et al.
Obesity (Silver Spring, Md.)|August 13, 2011
Large size cells in the visceral adipose depot predict insulin resistance in the canine modelMorvarid Kabir, Darko Stefanovski, Isabel R Hsu, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|April 30, 2021
Correction: Paszkiewicz et al. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting That Central Effects Can Be Avoided. <i>Int. J. Mol. Sci.</i> 2020, <i>21</i>, 6639Rebecca L Paszkiewicz, Richard N Bergman, Roberta S Santos, et al.
Obesity (Silver Spring, Md.)|May 24, 2023
Dapagliflozin prevents abdominal visceral and subcutaneous adipose tissue dysfunction in the insulin-resistant canine modelMorvarid Kabir, Richard N Bergman, Jay Porter, et al.
Endocrinology|January 17, 2014
Essentiality of portal vein receptors in hypoglycemic counterregulation: direct proof via denervation in male caninesViorica Ionut, Ana Valeria B Castro, Orison O Woolcott, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 9, 2006
Improvement of myocardial perfusion in coronary patients after intermittent hypobaric hypoxiaMaria del Pilar Valle, Félix García-Godos, Orison O Woolcott, et al.
Cell Calcium|April 20, 2006
Arachidonic acid is a physiological activator of the ryanodine receptor in pancreatic beta-cellsOrison O Woolcott, Amanda J Gustafsson, Mensur Dzabic, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 26, 2019
Activation of NPRs and UCP1-independent pathway following CB1R antagonist treatment is associated with adipose tissue beiging in fat-fed male dogsMalini S Iyer, Rebecca L Paszkiewicz, Richard N Bergman, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2014
Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemiaViorica Ionut, Ana Valeria B Castro, Orison O Woolcott, et al.
Plos One|July 12, 2016
Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-DiabetesViorica Ionut, Orison O Woolcott, Hasmik J Mkrtchyan, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 1, 2012
CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogsStella P Kim, Orison O Woolcott, Isabel R Hsu, et al.
Obesity (Silver Spring, Md.)|August 13, 2011
Large size cells in the visceral adipose depot predict insulin resistance in the canine modelMorvarid Kabir, Darko Stefanovski, Isabel R Hsu, et al.
Pageof 4